| Literature DB >> 25931726 |
Roberta Delasta Lazzari1, Fabiano Politti1, Cibele Alimedia Santos1, Arislander Jonathan Lopes Dumont1, Fernanda Lobo Rezende1, Luanda André Collange Grecco1, Luiz Alfredo Braun Ferreira1, Claudia Santos Oliveira1.
Abstract
[Purpose] The aim of the present study was to investigate the effects of a single session of transcranial direct current stimulation combined with virtual reality training on the balance of children with cerebral palsy. [Subjetcs and Methods] Children with cerebral palsy between four and 12 years of age were randomly allocated to two groups: an experimental group which performed a single session of mobility training with virtual reality combined with active transcranial direct current stimulation; and a control group which performed a single session of mobility training with virtual reality combined with placebo transcranial direct current stimulation. The children were evaluated before and after the training protocols. Static balance (sway area, displacement, velocity and frequency of oscillations of the center of pressure on the anteroposterior and mediolateral axes) was evaluated using a force plate under four conditions (30-second measurements for each condition): feet on the force plate with the eyes open, and with the eyes closed; feet on a foam mat with the eyes open, and with the eyes closed.Entities:
Keywords: Cerebral palsy; Electrical stimulation; Static balance
Year: 2015 PMID: 25931726 PMCID: PMC4395710 DOI: 10.1589/jpts.27.763
Source DB: PubMed Journal: J Phys Ther Sci ISSN: 0915-5287
Sway velocity before and after treatment in the AP and ML directions of the control and experimental groups with the eyes open (EO) and the eyes closed (EC) (Units: cm/s)
| Foam mat | Ground | ||||
|---|---|---|---|---|---|
| Pre | Post | Pre | Post | ||
| Control group | |||||
| COP-AP | EO | 12.52±2.56 | 13.26±1.87 | 15.97±3.83 | 14.48±2.46 |
| EC | 10.83±1.73 | 12.07±1.45 | 11.01±1.63 | 12.62±1.97 | |
| COP-ML | EO | 10.87±2.41 | 12.91±2.11** | 11.67±4.07 | 12.26±3.24* |
| EC | 10.47±3.08 | 10.64±1.79* | 11.67±4.07 | 11.92±2.31 | |
| Experimental group | |||||
| COP-AP | EO | 10.78±1.46 | 12.91±1.55 | 10.80±1.66 | 13.66±1.99** |
| EC | 9.85±1.31 | 13.13±1.58 | 9.52±0.47 | 13.21±1.93* | |
| COP-ML | EO | 8.68±1.30 | 12.90±2.09* | 9.58±2.03 | 11.96±2.05** |
| EC | 9.17±1.18 | 10.93±1.56* | 9.58±2.03 | 12.45±2.21** | |
Mean values (±SD) and significant differences between pre-and post-treatment are reported.
*p < 0.05; **p < 0.001: Bonferroni post hoc tests